BLBDBlue Bird Corporation

$56.32-5.7% 1Y

Is the business good?

Good

A genuinely good business: 8 of 9 health tests passed and earnings fully cash-backed (1.1×).

2 good, 1 neutral, 1 without data
Fundamental health (F-score)8 / 9SEC EDGAR · Sep 27, 2025

High fundamental quality. Nine pass/fail tests of year-over-year health from the filings.

Profits arrive as cash1.09×derived · Jun 27, 2026

Operating profit is fully backed by cash. Conversion is worsening vs a year ago.

Margin direction, 3 years+0.7 ptsderived

Margins have held roughly steady, a stable cost structure.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF conversionbehind 81% of the market
Leverage (Debt/EBITDA)top 10% of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is BLBD?

Blue Bird Corporation earns 24% on the capital it employs against a 9.0% cost of capital, so the business is worth more the bigger it gets.

24%

Return on invested capital · cost of capital 9.0% · 15 points above what the capital costs: growth creates value

Cash conversion
1.09×

Cash conversion · 1.57× a year ago · operating cash flow covers the operating profit after tax

Share count, year on year
+7.9%

Share count, year on year · shareholders own a smaller slice than a year ago

Operating margin by fiscal year
YearOperating margin
FY20202.5%
FY20210.95%
FY2022−5.1%
FY20234.6%
FY202410%
FY202511%
Details›
Free cash flow, trailing twelve months
$153M
Net income, trailing twelve months
$282M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
24%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.